IMPPAT Phytochemical information: 
7-[(3-Chlorobenzyl)oxy]-4-[(Methylamino)methyl]-2h-Chromen-2-One
7-[(3-Chlorobenzyl)oxy]-4-[(Methylamino)methyl]-2h-Chromen-2-One
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)A Phase 1 Clinical Study to Evaluate the Bioavailability of Pembrolizumab Via Subcutaneous Injection of MK-3475A, a Formulation of Pembrolizumab With MK-5180, in Participants With Advanced Solid TumorsNCT05017012
Mitochondrial Effects of C18:0 Supplementation in HumansMitochondrial Effects of C18:0 Supplementation in Type 2 Diabetics Versus Healthy ControlsNCT02957838
Effects of C16:0 versus C18:0 on HDL metabolism and other cardiometabolic risk markers: A dietary intervention study in healthy normal-weight and overweight subjectsEffects of C16:0 versus C18:0 on HDL metabolism and other cardiometabolic risk markers: A dietary intervention study in healthy normal-weight and overweight subjects - PASTEL (PAlmitic acid STEaric acid and Lipoproteins)NL-OMON46224
Saturated Fatty Acids and HDL MetabolismEffects of C16:0 Versus C18:0 on HDL Metabolism and Other Cardiometabolic Risk Markers: A Dietary Intervention Study in Healthy Normal-weight and Overweight SubjectsNCT02835651